Psychedex — Altered State Encyclopedia

Article Changes3 modified · 27 unchanged

The 7-HMG experience is [[substance_class:psychoactive/opioid|opioid]] in character: a spreading [[glossary:warmth|warmth]] that blunts physical pain, quiets emotional tension, and slows both body and mind. Nothing is amplified or brightened — everything quiets. The experience is defined by what it removes. Compared to [[substance:morphine|morphine]], the [[effect:pain-suppression|analgesia]] and [[effect:euphoria|euphoria]] are qualitatively similar, arising from the same [[glossary:receptor-activation|receptor activation]]. Concentrated [[glossary:semi-synthetic|semi-synthetic]] 7-HMG products produce a faster and more intense version of the same state than traditional [[substance:kratom|kratom]] preparations. No [[substance_class:psychoactive/psychedelic|psychedelic]] or hallucinogenic features have been documented at any dose.

The 7-HMG experience is [[substance_class:psychoactive/opioid|opioid]] in character: a spreading [[glossary:warmth|warmth]] that blunts physical pain and quiets emotional [[glossary:distress|distress]], accompanied by heavy [[effect:sedation|sedation]] and a narrowing of mental activity. At lower exposures — typical of traditional [[substance:kratom|kratom]] use, where 7-HMG forms gradually via [[glossary:metabolism|liver metabolism]] — the onset is gentle, the sedation moderate, and mild [[effect:stimulation|stimulation]] may coexist with analgesic warmth. At higher exposures from concentrated [[glossary:semi-synthetic|semi-synthetic]] products, the opioid qualities dominate: deeper sedation, stronger [[effect:euphoria|euphoria]], and pronounced respiratory slowing. No [[substance_class:psychoactive/psychedelic|psychedelic]], [[substance_class:psychoactive/dissociative|dissociative]], or hallucinogenic features have been reported at any dose. [[glossary:set-and-setting|Set and setting]] modulate the experience less than they do for psychedelics — the pharmacology is the primary driver.

Relative to [[substance:morphine|morphine]], 7-HMG produces qualitatively similar [[effect:pain-suppression|analgesia]] and euphoria through partial rather than full µ-opioid [[glossary:receptor-activation|receptor activation]]. All human experiential data come from kratom preparations containing the full alkaloid mixture, not from isolated 7-HMG — the precise boundary between this compound's contribution and that of co-administered kratom alkaloids remains undrawn.

The experiential character of [[substance:7-hydroxymitragynine|7-hydroxymitragynine]] is [[substance_class:psychoactive/opioid|opioid]]-typical — [[glossary:warmth|warmth]], [[effect:pain-suppression|analgesia]], [[effect:anxiety-suppression|anxiolysis]], and [[effect:sedation|sedation]] predominate — but all human data derive from [[substance:kratom|kratom]] preparations containing the full alkaloid mixture, not isolated 7-HMG. [[glossary:route-of-administration|Route of administration]] substantially shapes the experience: oral kratom delivers 7-HMG gradually via hepatic metabolic conversion from [[substance:mitragynine|mitragynine]], while [[glossary:semi-synthetic|semi-synthetic]] [[glossary:sublingual|sublingual]] and nasal formulations bypass [[glossary:first-pass-metabolism|first-pass metabolism]], producing [[glossary:rapid-onset|rapid-onset]] effects at potentially greater [[glossary:intensity|intensity]]. No [[substance_class:psychoactive/psychedelic|psychedelic]], [[substance_class:psychoactive/dissociative|dissociative]], or hallucinogenic features have been documented at any dose. Relative to [[substance:morphine|morphine]], 7-HMG produces qualitatively similar analgesia and [[effect:euphoria|euphoria]] through partial rather than full [[glossary:mu-opioid-receptor|mu-opioid receptor]] agonism and G-protein-biased signaling. Its metabolic cascade — generating the even more potent mitragynine pseudoindoxyl in human [[glossary:plasma|plasma]] — and the absence of controlled human studies of isolated 7-HMG mean the precise experiential boundary between this compound and co-administered kratom alkaloids remains unresolved.

7-Hydroxymitragynine